Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1811017 10.3389/fphar.2026.1811017 Correction Correction: Fibroblast growth factor receptor inhibitors in glioma: a narrative review of recent advances Han et al. 10.3389/fphar.2026.1811017 Han Mingyu 1 2 Project administration Visualization Writing - original draft Writing - review and editing Zhou Zhaokai 3 Writing - review and editing Qian Bi 4 Writing - review and editing Zhang Yuanqi 5 * Supervision Writing - review and editing Peng Cheng 2 * Supervision Writing - review and editing Peng Fu 1 6 * Funding acquisition Project administration Supervision Writing - review and editing West China School of Pharmacy, Sichuan University, Chengdu, China Key Laboratory of Standardization of Chinese Medicine (Chengdu University of Traditional Chinese Medicine), Ministry of Education, Chengdu, China Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Guangzhou, China Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, Sichuan University, Chengdu, China Correspondence: Yuanqi Zhang, zhangyuanqi@gdmu.edu.cn; Cheng Peng, pengcheng@cdutcm.edu.cn; Fu Peng, pengf@scu.edu.cn 24 02 2026 2026 17 1811017 14 02 2026 18 02 2026 Copyright © 2026 Han, Zhou, Qian, Zhang, Peng and Peng. 2026 Han, Zhou, Qian, Zhang, Peng and Peng https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on Fibroblast growth factor receptor inhibitors in glioma: a narrative review of recent advances by Han M, Zhou Z, Qian B, Zhang Y, Peng C and Peng F (2026). Front. Pharmacol. 16:1714696. doi: 10.3389/fphar.2025.1714696 glioma fibroblast growth factor receptor (FGFR) pathways gene fusion inhibitors section-at-acceptance Pharmacology of Anti-Cancer Drugs

Author Yuanqi Zhang was erroneously spelled as Qiyuan Zhang.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland